ATRX and pancreatic neuroendocrine tumor: The authors pointed out that the late emergence of ALT features observed upon the loss of ATRX/DAXX in their experiments was consistent with observations in pancreatic neuroendocrine tumor biopsies of different stages by Marinoni et al. [166], indicating that the loss of ATRX or DAXX occurred well before ALT development.